Cargando…
The Effect of Adherence to Screening Guidelines on the Risk of Alzheimer’s Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes Mellitus
Objective: The aim of this study was to examine the possibility that type 2 diabetes and Alzheimer’s disease may share common behavioral protective factors such as adherence to type 2 diabetes treatment guidelines given that these two diseases have both epidemiological and metabolic similarities. Me...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236474/ https://www.ncbi.nlm.nih.gov/pubmed/30450369 http://dx.doi.org/10.1177/2333721418811201 |
_version_ | 1783371040025477120 |
---|---|
author | Yashkin, Arseniy P. Akushevich, Igor Ukraintseva, Svetlana Yashin, Anatoliy |
author_facet | Yashkin, Arseniy P. Akushevich, Igor Ukraintseva, Svetlana Yashin, Anatoliy |
author_sort | Yashkin, Arseniy P. |
collection | PubMed |
description | Objective: The aim of this study was to examine the possibility that type 2 diabetes and Alzheimer’s disease may share common behavioral protective factors such as adherence to type 2 diabetes treatment guidelines given that these two diseases have both epidemiological and metabolic similarities. Method: The method used in this study is a retrospective cohort study of 3,797 U.S. Medicare fee-for-service beneficiaries aged 66+ newly diagnosed with type 2 diabetes and without a prior record of Alzheimer’s disease based on the Health and Retirement Study. Results: Results of a left-truncated Cox model showed that adherence reduces the risk of Alzheimer’s disease by 20% to 24%. Other significant effects were college education (hazard ratio [HR]: 0.65; p value: .023), stroke (HR: 1.40; p value: .013), and 4+ limitations in physical functioning (HR: 1.33; p value: .008). Discussion: Risk of Alzheimer’s disease can be reduced by behavioral factors. Possible mechanisms may include earlier start of interventions to reduce blood glucose levels and improve insulin sensitivity. |
format | Online Article Text |
id | pubmed-6236474 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-62364742018-11-16 The Effect of Adherence to Screening Guidelines on the Risk of Alzheimer’s Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes Mellitus Yashkin, Arseniy P. Akushevich, Igor Ukraintseva, Svetlana Yashin, Anatoliy Gerontol Geriatr Med Article Objective: The aim of this study was to examine the possibility that type 2 diabetes and Alzheimer’s disease may share common behavioral protective factors such as adherence to type 2 diabetes treatment guidelines given that these two diseases have both epidemiological and metabolic similarities. Method: The method used in this study is a retrospective cohort study of 3,797 U.S. Medicare fee-for-service beneficiaries aged 66+ newly diagnosed with type 2 diabetes and without a prior record of Alzheimer’s disease based on the Health and Retirement Study. Results: Results of a left-truncated Cox model showed that adherence reduces the risk of Alzheimer’s disease by 20% to 24%. Other significant effects were college education (hazard ratio [HR]: 0.65; p value: .023), stroke (HR: 1.40; p value: .013), and 4+ limitations in physical functioning (HR: 1.33; p value: .008). Discussion: Risk of Alzheimer’s disease can be reduced by behavioral factors. Possible mechanisms may include earlier start of interventions to reduce blood glucose levels and improve insulin sensitivity. SAGE Publications 2018-11-13 /pmc/articles/PMC6236474/ /pubmed/30450369 http://dx.doi.org/10.1177/2333721418811201 Text en © The Author(s) 2018 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Article Yashkin, Arseniy P. Akushevich, Igor Ukraintseva, Svetlana Yashin, Anatoliy The Effect of Adherence to Screening Guidelines on the Risk of Alzheimer’s Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes Mellitus |
title | The Effect of Adherence to Screening Guidelines on the Risk of
Alzheimer’s Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes
Mellitus |
title_full | The Effect of Adherence to Screening Guidelines on the Risk of
Alzheimer’s Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes
Mellitus |
title_fullStr | The Effect of Adherence to Screening Guidelines on the Risk of
Alzheimer’s Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes
Mellitus |
title_full_unstemmed | The Effect of Adherence to Screening Guidelines on the Risk of
Alzheimer’s Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes
Mellitus |
title_short | The Effect of Adherence to Screening Guidelines on the Risk of
Alzheimer’s Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes
Mellitus |
title_sort | effect of adherence to screening guidelines on the risk of
alzheimer’s disease in elderly individuals newly diagnosed with type 2 diabetes
mellitus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236474/ https://www.ncbi.nlm.nih.gov/pubmed/30450369 http://dx.doi.org/10.1177/2333721418811201 |
work_keys_str_mv | AT yashkinarseniyp theeffectofadherencetoscreeningguidelinesontheriskofalzheimersdiseaseinelderlyindividualsnewlydiagnosedwithtype2diabetesmellitus AT akushevichigor theeffectofadherencetoscreeningguidelinesontheriskofalzheimersdiseaseinelderlyindividualsnewlydiagnosedwithtype2diabetesmellitus AT ukraintsevasvetlana theeffectofadherencetoscreeningguidelinesontheriskofalzheimersdiseaseinelderlyindividualsnewlydiagnosedwithtype2diabetesmellitus AT yashinanatoliy theeffectofadherencetoscreeningguidelinesontheriskofalzheimersdiseaseinelderlyindividualsnewlydiagnosedwithtype2diabetesmellitus AT yashkinarseniyp effectofadherencetoscreeningguidelinesontheriskofalzheimersdiseaseinelderlyindividualsnewlydiagnosedwithtype2diabetesmellitus AT akushevichigor effectofadherencetoscreeningguidelinesontheriskofalzheimersdiseaseinelderlyindividualsnewlydiagnosedwithtype2diabetesmellitus AT ukraintsevasvetlana effectofadherencetoscreeningguidelinesontheriskofalzheimersdiseaseinelderlyindividualsnewlydiagnosedwithtype2diabetesmellitus AT yashinanatoliy effectofadherencetoscreeningguidelinesontheriskofalzheimersdiseaseinelderlyindividualsnewlydiagnosedwithtype2diabetesmellitus |